When Signals Cross: Medical Systems at CSAIL
Professor John Guttag and his team of graduate students are working in partnership with clinicians to produce technological solutions for medical problems.
3 Questions: Jeffrey Harris on why we still don't have an HIV vaccine
The MIT economist blames inadequate incentives for the failure to develop a vaccine against the virus that causes AIDS. He argues governments should help industry create an HIV vaccine by sharing risk.
Remembering David Schauer
Professor’s ‘academic family’ recalls the life and work of the infectious disease expert.
More jabs needed
Study suggests that vaccinating many more people could slow the seasonal influenza virus's ability to evade vaccines.
A new way to measure muscle
MIT engineer Joel Dawson and colleagues built a handheld probe that could help doctors monitor muscle atrophy in patients with Lou Gehrig's Disease and similar ailments.
Cancer research gets physical
5-year grant from the National Cancer Institute will fund projects by physicists that give a new view of cancer cells.
Protein is linked to lung cancer development
Drugs that inhibit the protein, which normally helps defend cells from infection, could target tumors in certain lung cancer patients.
In Profile: Leonard Guarente
Biology professor discovered a gene at the center of aging. Now that research is yielding therapies that target the diseases of old age.
Taking aim at aggressive cancer cells
Researchers use novel stem-cell method to discover chemical with potency against breast tumors in mice
Tumor mutations can predict chemo success
Genetic profiling of tumors could have 'immediate impact' on treating cancer, study shows